Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

LRRC32 Protein (partial) (Fc Tag)

LRRC32 Origine: Humain Hôte: HEK-293 Cells Recombinant >95 % as determined by SDS-PAGE. WB, ELISA Active
N° du produit ABIN5608431
  • Antigène Voir toutes LRRC32 Protéines
    LRRC32 (Leucine Rich Repeat Containing 32 (LRRC32))
    Type de proteíne
    Recombinant
    Activité biologique
    Active
    Attributs du protein
    partial
    Origine
    • 6
    • 2
    • 2
    Humain
    Source
    • 4
    • 3
    • 2
    HEK-293 Cells
    Purification/Conjugué
    Cette LRRC32 protéine est marqué à la Fc Tag.
    Application
    Western Blotting (WB), ELISA
    Séquence
    His 20 - Asn 627
    Pureté
    >95 % as determined by SDS-PAGE.
    niveau d'endotoxine
    Endotoxin level is less than 1.0 EU per ug by the LAL method.
    Biological Activity Comment

    Measured by its binding ability in a functional ELISA. Immobilized Latent TGFB1, N-His at 5 μg/mL (100 uL/well) can bind Human LRRC32, Fc Tag with a linear range of 0.039-2.5 μg/mL (QC tested).

    Top Product
    Discover our top product LRRC32 Protéine
  • Indications d'application
    This recombinant protein can be used for E, WB.
    Restrictions
    For Research Use only
  • Format
    Lyophilized
    Buffer
    50 mM Tris, 100 mM Glycine, pH 7.5
    Conseil sur la manipulation
    Avoid repeated freeze-thaw cycles.
    Stock
    -20 °C,-80 °C
    Stockage commentaire
    Lyophilized Protein should be stored at -20°C or lower for long term storage. Upon reconstitution, working aliquots should be stored at -20°C or -70°C.
  • Antigène
    LRRC32 (Leucine Rich Repeat Containing 32 (LRRC32))
    Autre désignation
    LRRC32 (LRRC32 Produits)
    Synonymes
    D11S833E Protein, GARP Protein, AI426318 Protein, D11S833Eh Protein, D7H11S833E Protein, EG434215 Protein, Garp Protein, leucine rich repeat containing 32 Protein, LRRC32 Protein, Lrrc32 Protein
    Sujet
    Leucine-rich repeat protein 32 (LRRC32), also known as GARP (glycoprotein A repetitions predominant). LRRC32 expression promotes the acquisition of a Treg phenotype including reduced cellular proliferation, reduced cytokine secretion, and the capacity to suppress the proliferation of naive T cells. LRRC32 binds directly to the TGF-beta latency associated peptide (LAP) and tethers latent TGF-beta on the surface of activated Treg cells. The presentation of TGF-beta on Tregs contributes to their ability to suppress naive T cell proliferation.
    Poids moléculaire
    92.6 kDa
    ID gène
    2615
    Pathways
    Activated T Cell Proliferation
Vous êtes ici:
Support technique